Shaun Donegan in Ewa Beach, Hawaii

Home Hawaii Ewa Beach

Shaun Donegan has Medical Oncology as his primary medical specialty. Their primary office is: 91 -2135 Fort Weaver Rd in Ewa Beach, Hawaii. There are 3 additional office locations for Shaun Donegan that can be viewed towards the end of their profile.

They're a part of the: The Queens Medical Center medical group which has around 192 members. You can call their office at 808-691-3020 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Tulane University School Of Medicine and graduated in 2005 (around 19 years of experience). They are listed as doing telehealth appointments.

Shaun Donegan Office Phone and Directions

Shaun Donegan
The Queens Medical Center
91 -2135 Fort Weaver Rd
Ewa Beach, Hawaii 96706
808-691-3020

Patient Ratings
Please rate your experience with Shaun Donegan below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 808-691-3020

Enter a starting address:

Healthcare Info for Shaun Donegan

Medical School: Tulane University School Of Medicine
Graduation Year: 2005
The Primary Medical Specialty for Shaun Donegan is listed as: Medical Oncology
Approximate Years of Experience: 19
PAC (PECOS ID)#: 1254465206
NPI #: 1104038249
NPI Created On: 05/03/2007
NPI Last Updated Listed as: 11/14/2023
Primary Taxonomy Code: 207RX0202X
License Number:
2010-00391
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Celtic Insurance Company
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787756096

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787756073

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787756083

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787756106

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787756115

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787756125

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787756137

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 790253445

Being Disputed:: No

Product Related: No

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 790254139

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: Rubraca

Open Associated Drug #1: 69660-201-91

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781016851

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Additional Office Locations

1. The Queens Medical Center
1380 Lusitana St
Honolulu, HI 96813
Suite 608
Group Members: 192

Phone: 808-691-3020

Enter a starting address:

2. The Queens Medical Center
321 N Kuakini St
Honolulu, HI 96817
Suite 412
Group Members: 192

Phone: 808-691-3020

Enter a starting address:

3. The Queens Medical Center
550 S Beretania St
Honolulu, HI 96813
Group Members: 192

Enter a starting address:

Medical Oncology Professionals in Ewa Beach

1.
Yoshihito Saito

91 -2135 Fort Weaver Rd
Ewa-beach, HI
The Queens Medical Center

2.
Yoshihito Saito

91 -2127 Fort Weaver Rd
Ewa-beach, HI
The Queens Medical Center

Providers in The Queens Medical Center

1.Omar Abdul Ghani

550 S Beretania St
Honolulu Hi 96813-2496
The Queens Medical Center
Cardiovascular Disease (cardiology)

2.Danilo Ablan Md

91 -2127 Fort Weaver Rd
Ewa Beach Hi 96706-1993
The Queens Medical Center
Pulmonary Disease

3.Danilo Ablan Md

550 S Beretania St
Honolulu Hi 96813-2496
The Queens Medical Center
Pulmonary Disease

4.Jared Acoba

1301 Punchbowl St
Honolulu Hi 96813-2402
The Queens Medical Center
Hematology/oncology

5.Gerard Akaka

2670 Pacific Heights Rd
Honolulu Hi 96813-1049
The Queens Medical Center
Internal Medicine

6.Gerard Akaka

1329 Lusitana St
Honolulu Hi 96813-2401
The Queens Medical Center
Internal Medicine

View all 192 members of The Queens Medical Center medical group